Cardiovascular diseases
Cereno builds momentum for major clinical milestones
Cereno Scientific has announced clear progress in its Phase II clinical trial with the lead drug candidate CS1. The study, which includes...
Newly formed research consortium granted SEK 12 million from the Knowledge Foundation
A new research project where both industry and academia partners...
Cereno Scientific strengthens its pipeline through second acquisition of the year
Cereno Scientific is developing a platform for cardiovascular therapies...
The plate in the carpet for Cereno Scientific
Cereno Scientific has been very communicative in the last...
Cereno Scientific goes to the bank with a surplus of cash after an oversubscribed share issue
Gothenburg-based pharmaceutical company Cereno Scientific can now replenish...
Cereno Scientific funds rush towards Phase II
Cereno Scientific develops breakthrough drugs for cardiovascular diseases...
Cereno Scientific carries out rights issue of SEK 56 million
Today, Cereno Scientific announced its intention to conduct...
CEO Interview Cereno Scientific: Important progress in 2018 followed by more in 2019
During the BioStock Live Startup pitch & Dealmaker Summit...